Minjuvi 200 mg

Minjuvi 200 mg is a medicine authorised by Swissmedic under authorisation number 68083. The authorisation holder is Incyte Biosciences International Sàrl. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 March 2022 and the authorisation is limited until 20 May 2030. ATC code L01FX12 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68083
  • ATC L01FX12
  • Biotechnological medicines
Authorisation data
Authorisation number68083
NameMinjuvi 200 mg
Full nameMinjuvi 200 mg, poudre pour solution à diluer pour perfusion
Authorisation holderIncyte Biosciences International Sàrl
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX12
First authorisation22 March 2022
Authorisation validity20 May 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Minjuvi 200 mg, poudre pour solution à diluer pour perfusionA22 March 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX1207.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Minjuvi 200 mg authorised in Switzerland?

Yes. Minjuvi 200 mg is authorised by Swissmedic under authorisation number 68083, data as of 01 September 2026. The authorisation is limited until 20 May 2030.

Which dispensing category does Minjuvi 200 mg have?

Minjuvi 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Minjuvi 200 mg?

The authorisation holder is Incyte Biosciences International Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com